A patient with Stage 4 chronic kidney disease presents with significant bilateral pitting edema, elevated blood pressure, and hyperkalemia. Given these findings, which nursing intervention should be prioritized to address the patient's current condition?

C) Implement dietary modifications to reduce potassium intake and manage fluid balance

A) Encourage increased oral fluid intake to dilute serum potassium levels

B) Administer prescribed erythropoiesis-stimulating agents to manage anemia

C) Implement dietary modifications to reduce potassium intake and manage fluid balance

D) Monitor for signs of infection due to potential immunocompromise

A patient with Stage 4 chronic kidney disease presents with bilateral pitting edema, nocturia, fatigue, crackles at lung bases, blood pressure of 150/95 mmHg, elevated creatinine, and hyperkalemia. Which nursing intervention should be prioritized to address the patient's risk for cardiac complications?

B) Administer a prescribed loop diuretic to reduce fluid overload.

A) Encourage the patient to increase fluid intake.

B) Administer a prescribed loop diuretic to reduce fluid overload.

C) Advise the patient to consume more potassium-rich foods.

D) Discontinue all antihypertensive medications immediately.

A patient with advanced chronic kidney disease presents with worsening shortness of breath, increased serum potassium, and signs of fluid overload. Which nursing intervention is most appropriate to address the patient's current condition?

C) Prepare the patient for initiation of dialysis treatment

A) Encourage increased fluid intake to improve hydration

B) Administer a potassium-sparing diuretic to manage fluid overload

C) Prepare the patient for initiation of dialysis treatment

D) Educate the patient on reducing dietary protein intake

A patient with advanced chronic kidney disease (CKD) and hyperkalemia presents with increased shortness of breath and reduced exercise tolerance. Her blood pressure is 152/97 mmHg, heart rate is 102 bpm, and lung auscultation reveals widespread crackles. Laboratory tests show a serum potassium level of 6.0 mmol/L and a low eGFR of 26 mL/min/1.73m². Which nursing intervention is most appropriate to prioritize at this time?

B) Administer diuretic therapy to manage fluid overload and monitor electrolyte changes.

A) Encourage the patient to increase dietary potassium intake to balance electrolyte levels.

B) Administer diuretic therapy to manage fluid overload and monitor electrolyte changes.

C) Discontinue the ACE inhibitor to immediately lower potassium levels.

D) Initiate erythropoiesis-stimulating agent therapy to address anemia and improve oxygenation.

A patient with chronic kidney disease is experiencing worsening fluid overload and elevated potassium levels. After initiating diuretic therapy with furosemide, the patient reports slight improvement in breathing and decreased peripheral edema, but her blood pressure remains poorly controlled at 148/95 mmHg. Considering her current clinical status, which intervention should the nurse prioritize to address the patient's overall management needs?

C) Collaborate with the healthcare team to optimize antihypertensive therapy and assess for potential iron deficiency.

A) Increase the dose of furosemide to enhance diuresis and further reduce fluid overload.

B) Initiate a low-potassium diet to further reduce serum potassium levels and prevent hyperkalemia.

C) Collaborate with the healthcare team to optimize antihypertensive therapy and assess for potential iron deficiency.

D) Schedule an urgent dialysis session to address fluid overload and correct electrolyte imbalances.

A patient with chronic kidney disease (CKD) and recent initiation of furosemide therapy reports nocturnal dyspnea and orthopnea. The healthcare team is considering initiating dialysis due to progressive renal deterioration and persistent symptoms. Which nursing intervention is most critical to address the patient's current symptoms while awaiting further diagnostic evaluation?

B) Position the patient in a semi-Fowler's position to facilitate breathing.

A) Encourage the patient to increase fluid intake to improve hydration.

B) Position the patient in a semi-Fowler's position to facilitate breathing.

C) Administer an additional dose of furosemide to reduce fluid overload.

D) Instruct the patient to perform deep breathing exercises to alleviate anxiety.

A patient with heart failure with reduced ejection fraction (HFrEF) has been started on lisinopril and carvedilol. The nurse is reviewing the patient's lab results. Which laboratory finding would require immediate follow-up with the healthcare provider?

A) Serum potassium level of 5.2 mEq/L

B) Serum creatinine level of 2.0 mg/dL

C) Blood urea nitrogen (BUN) of 25 mg/dL

A patient with heart failure with reduced ejection fraction (HFrEF) and chronic kidney disease is started on lisinopril and carvedilol. Which assessment finding should prompt the nurse to contact the healthcare provider immediately?

B) Serum potassium level of 5.8 mEq/L

A) Blood pressure of 140/88 mmHg

B) Serum potassium level of 5.8 mEq/L

C) Heart rate of 70 beats per minute

D) Mild improvement in dyspnea symptoms

chronic kidney disease progressing to kidney replacement - Nursing Case Study

Pathophysiology

• Primary mechanism: Progressive nephron loss leads to decreased glomerular filtration rate (GFR), causing accumulation of waste products and fluid imbalances, further exacerbating nephron damage.

• Secondary mechanism: Chronic hyperfiltration in remaining nephrons causes glomerular hypertension and sclerosis, promoting further nephron injury and loss, accelerating renal function decline.

• Key complication: Persistent uremia and fluid overload may result in systemic complications like hypertension and cardiovascular disease, eventually necessitating kidney replacement therapy to sustain life.

Patient Profile

Demographics:

57-year-old female, retired school teacher

History:

• Hypertension, Type 2 Diabetes, Chronic Kidney Disease Stage 3

• Lisinopril 10 mg daily, Metformin 1000 mg twice daily, Atorvastatin 20 mg daily

• Allergic to penicillin

Current Presentation:

• Chief complaint: Increasing fatigue and swelling in legs

• Key symptoms: Fatigue, peripheral edema, nocturia, decreased appetite, muscle cramps

• Vital signs: Blood pressure 150/95 mmHg, heart rate 92 bpm, respiratory rate 20 breaths per minute, temperature 98.6°F, oxygen saturation 96% on room air

Section 1

During her initial assessment, the patient presents with worsening symptoms indicative of advancing chronic kidney disease. The nurse notes significant bilateral pitting edema in the lower extremities, extending up to the knees. The patient reports increasing nocturia and persistent fatigue, which have begun to interfere with daily activities. Upon auscultation, mild crackles are heard at the lung bases, suggesting fluid overload. The patient’s blood pressure remains elevated at 150/95 mmHg, despite adherence to antihypertensive therapy, raising concerns about the adequacy of current medication management and potential cardiovascular strain.

Laboratory results reveal a further decline in renal function, with creatinine levels elevated at 2.6 mg/dL and an estimated glomerular filtration rate (eGFR) reduced to 28 mL/min/1.73m², indicating progression to Stage 4 chronic kidney disease. Blood urea nitrogen (BUN) is also elevated at 48 mg/dL, consistent with worsening uremia. Additionally, serum potassium is noted at 5.5 mmol/L, highlighting a risk for hyperkalemia, an electrolyte disturbance that requires prompt attention due to potential cardiac complications. The patient's hemoglobin level has decreased to 10.2 g/dL, suggesting anemia of chronic disease, which may further contribute to her fatigue and diminished quality of life.

These findings necessitate a reassessment of her current treatment plan, including potential adjustments to her antihypertensive regimen and consideration of initiating erythropoiesis-stimulating agents to manage anemia. The healthcare team must also evaluate the need for dietary modifications to address hyperkalemia and fluid overload, while exploring the timing and appropriateness of introducing discussions around kidney replacement therapy options, such as dialysis or kidney transplantation. This evolving clinical picture underscores the need for proactive management to mitigate further complications and optimize the patient's overall health and well-being.

Section 2

Following the initial assessment and subsequent diagnostic evaluations, the healthcare team decided to adjust the patient's antihypertensive therapy to better manage her blood pressure and mitigate cardiovascular risks. The patient's regimen was modified to include a combination of an angiotensin-converting enzyme (ACE) inhibitor and a calcium channel blocker, aiming to optimize blood pressure control and provide renal protection. Dietary modifications were also implemented, specifically a low-potassium diet to address her hyperkalemia. The patient was educated on avoiding high-potassium foods such as bananas, oranges, and potatoes. Additionally, an erythropoiesis-stimulating agent was initiated to combat anemia and improve her energy levels, with the expectation of gradual improvement in hemoglobin over subsequent weeks.

Despite these interventions, the patient experienced a change in her clinical status two weeks later. She presented to the clinic with complaints of increased shortness of breath and a noticeable decline in exercise tolerance. On examination, her blood pressure remained elevated at 152/97 mmHg, and her heart rate was slightly tachycardic at 102 beats per minute. Upon auscultation, the crackles at the lung bases had progressed to more widespread areas, raising concerns about worsening fluid overload. Repeat laboratory tests revealed a further increase in serum potassium to 6.0 mmol/L and a persistently low eGFR of 26 mL/min/1.73m², alongside a slight decrease in hemoglobin to 9.8 g/dL.

These findings prompted an urgent review of her treatment plan, emphasizing the need for more aggressive management of her fluid status. The healthcare team considered the initiation of diuretic therapy to alleviate pulmonary congestion and reduce edema, while monitoring for potential electrolyte imbalances. The potential need for renal replacement therapy was revisited, with discussions around starting dialysis becoming increasingly pertinent. This evolving scenario highlights the complexity of managing advanced chronic kidney disease and underscores the necessity for ongoing clinical vigilance and timely intervention to prevent further complications and enhance the patient's quality of life.

Section 3

In response to the patient's worsening fluid overload and elevated potassium levels, the healthcare team initiated diuretic therapy with furosemide to enhance fluid removal and reduce pulmonary congestion. The patient was closely monitored for signs of electrolyte imbalance, particularly hypokalemia, given her concurrent hyperkalemia. Over the subsequent days, the patient reported a slight improvement in her breathing and decreased peripheral edema. However, despite these positive changes, her blood pressure remained poorly controlled at 148/95 mmHg, and she continued to experience fatigue and decreased exercise tolerance.

New laboratory results revealed a slight improvement in her serum potassium, now at 5.7 mmol/L, yet her eGFR had declined further to 24 mL/min/1.73m², signaling progressive renal deterioration. Her hemoglobin level remained low at 9.6 g/dL despite ongoing erythropoiesis-stimulating therapy, suggesting potential inadequate response or underlying causes such as iron deficiency or inflammation. The patient's clinical course prompted a reassessment of her overall management strategy, including the optimization of antihypertensive therapy and the potential need for iron supplementation.

Amid these developments, the patient experienced new complications characterized by nocturnal dyspnea and orthopnea, raising concerns about cardiac stress and the possibility of congestive heart failure exacerbation. A chest X-ray confirmed pulmonary congestion, and an echocardiogram was scheduled to evaluate cardiac function and rule out left ventricular dysfunction. The healthcare team intensified discussions regarding the initiation of dialysis, considering her declining renal function and persistent symptoms. This evolving case study emphasizes the intricate interplay of cardiovascular and renal considerations in managing chronic kidney disease, necessitating a comprehensive and dynamic approach to care.

Section 4

Following the decision to perform an echocardiogram, the results revealed mild left ventricular hypertrophy and an ejection fraction of 45%, indicative of systolic dysfunction. This finding confirmed the suspicion of heart failure with reduced ejection fraction (HFrEF) contributing to the patient's symptoms of nocturnal dyspnea and orthopnea. The patient's vital signs showed persistent hypertension with a blood pressure of 150/92 mmHg and a heart rate of 88 beats per minute. Her respiratory rate was slightly elevated at 22 breaths per minute, and she continued to experience moderate dyspnea on exertion. The clinical team noted bilateral crackles upon auscultation of the lung bases, consistent with ongoing pulmonary congestion.

In response to these findings, the healthcare team decided to adjust the patient's medication regimen to better manage her heart failure and hypertension. An ACE inhibitor, lisinopril, was introduced to address both her elevated blood pressure and cardiac dysfunction, with careful monitoring of renal function and potassium levels due to the risk of hyperkalemia. Additionally, a beta-blocker, carvedilol, was prescribed to improve cardiac output and reduce the heart's workload. The team also emphasized the importance of dietary modifications, including sodium and fluid restrictions, to help manage fluid overload.

As the patient began the new medication regimen, she reported a slight reduction in her symptoms of dyspnea and fatigue after a few days. Her blood pressure showed modest improvement, averaging 140/88 mmHg. However, the need for dialysis remained a critical consideration given her declining renal function and persistent symptoms. The interdisciplinary team, including nephrologists and cardiologists, continued to closely monitor her progress, ready to escalate her treatment plan to include renal replacement therapy if her condition failed to stabilize. This ongoing case underscores the need for a coordinated, multifaceted approach to managing the complex interplay of chronic kidney disease and heart failure, requiring vigilant assessment and timely interventions.

Section 5

As the patient's treatment progressed, the healthcare team noted a significant change in her status, signaling new complications that required immediate attention. Despite the initial stabilization of her blood pressure and slight improvement in dyspnea, the patient began experiencing episodes of dizziness and palpitations. Her vital signs revealed fluctuating blood pressure readings, with occasional drops to 110/70 mmHg, and her heart rate varied between 60 to 110 beats per minute, suggesting possible arrhythmias. An electrocardiogram (ECG) was performed, revealing frequent premature ventricular contractions and occasional runs of ventricular tachycardia, raising concerns about her cardiac stability.

In response to these findings, the medical team reassessed her medication regimen, considering the potential side effects of her current treatments. The carvedilol dose was cautiously adjusted, with plans to initiate low-dose antiarrhythmic therapy if the arrhythmias persisted. Concurrently, her renal function tests showed a further decline, with serum creatinine levels rising to 3.1 mg/dL and estimated glomerular filtration rate (eGFR) dropping to 25 mL/min/1.73 m², indicating worsening kidney function. This prompted an urgent discussion about the timing and modality of renal replacement therapy, with hemodialysis being the most viable option given her current condition.

These new developments highlighted the delicate balance required in managing her complex medical conditions. The team emphasized the importance of continuous monitoring and timely interventions to prevent further deterioration. The patient's case was reviewed in a multidisciplinary team meeting to ensure that both her cardiac and renal needs were adequately addressed, reflecting the intricate interplay between her heart failure and advancing chronic kidney disease. As the team prepared for potential dialysis initiation, they remained vigilant for any further complications, ready to adapt her treatment plan as necessary to optimize her outcomes.